MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis.
Endometriosis is a common gynecologic disorder characterized by pain and infertility. In addition to estrogen dependence, progesterone resistance is an emerging feature of this disorder. Specifically, a delayed transition from the proliferative to secretory phase as evidenced by dysregulation of progesterone target genes and maintenance of a proliferative molecular fingerprint in the early secretory endometrium (ESE) has been reported. MicroRNAs (miRNAs) are small noncoding RNAs that collectively represent a novel class of regulators of gene expression. In an effort to investigate further the observed progesterone resistance in the ESE of women with endometriosis, we conducted array-based, global miRNA profiling. We report distinct miRNA expression profiles in the ESE of women with versus without endometriosis in a subset of samples previously used in global gene expression analysis. Specifically, the miR-9 and miR-34 miRNA families evidenced dysregulation. Integration of the miRNA and gene expression profiles provides unique insights into the molecular basis of this enigmatic disorder and, possibly, the regulation of the proliferative phenotype during the early secretory phase of the menstrual cycle in affected women.
Burney
R O
RO
Division of Reproductive Endocrinology and Infertility, Madigan Army Medical Center, Tacoma, WA, USA.
Hamilton
A E
AE
Aghajanova
L
L
Vo
K C
KC
Nezhat
C N
CN
Lessey
B A
BA
Giudice
L C
LC
D000328:Adult; D004715:Endometriosis / Q000235:genetics*; D004717:Endometrium / Q000378:metabolism*; D005260:Female; D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D055815:Young Adult
D035683:MicroRNAs
Nat Genet. 2005 May;37(5):495-500
15806104
Nature. 2005 Feb 17;433(7027):769-73
15685193
Genes Chromosomes Cancer. 2007 Apr;46(4):336-47
17243163
DNA Cell Biol. 2007 Apr;26(4):195-207
17465886
Cancer Res. 2007 Sep 15;67(18):8433-8
17823410
Cancer Res. 2007 Sep 15;67(18):8699-707
17875710
Fertil Steril. 2010 Apr;93(6):2027-34
18555231
Mol Cancer. 2008 Apr 28;7:35
18442408
Nature. 2004 Sep 16;431(7006):350-5
15372042
Obstet Gynecol Clin North Am. 1997 Jun;24(2):235-58
9163765
Mod Pathol. 2006 Dec;19(12):1615-23
16980942
Am J Obstet Gynecol. 1975 May;122(2):262-3
1155504
Mol Endocrinol. 2009 Feb;23(2):265-75
19074548
Endocrinology. 2007 Aug;148(8):3814-26
17510236
Fertil Steril. 2005 Jul;84(1):12-5
16009147
Biol Reprod. 2009 Jan;80(1):105-14
18815356
J Clin Endocrinol Metab. 2008 Sep;93(9):3490-8
18559911
Cell. 2005 Jan 14;120(1):15-20
15652477
Fertil Steril. 2010 Mar 1;93(4):1255-9
19131054
Mol Hum Reprod. 2007 Nov;13(11):797-806
17766684
Science. 2007 Dec 21;318(5858):1931-4
18048652
Nat Methods. 2006 Jan;3(1):41-6
16369552
Methods. 2001 Dec;25(4):402-8
11846609